BIOMARKERS US 2024
BIOMARKERS US 2024
Ensuring robust biomarker validation & identification to improve clinical outcomes, enable better diagnosis & facilitate precision medicine
Explore Biomarkers US 2024: Addressing Challenges Across The Biomarkers Discovery & Development Landscape
Explore the latest developments in the biomarker field through the 8th Annual Biomarker & Precision Medicine US Congress, which brings together experts from global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions all focussed on emerging tools and strategies within translational science, diagnostics and biomarker development.
8th Annual Biomarker & Precision Medicine US Congress
Enable effective biomarker identification and characterization across multiple disease areas, including neuroscience, oncology & rare disease, to accelerate novel drug candidates to commercially successful products
Integrate multi-omic technologies into your workflows to drive the development of precision medicines, with discussion of spatial technologies, single cell analysis and AI-driven imaging
Gain novel insights into next-generation diagnostic tools in order to improve clinical outcomes. Further talks look at the implementation of companion diagnostics in drug development to enable therapeutic success
What to Expect
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences.
Engaging Thought Leadership
Over 60 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts.
Global Technological Showcase
An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
Innovative Poster Displays
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions
Key Themes for Biomarkers US 2024
The 2024 programme will delve into the intricacies of navigating regulatory barriers in clinical trials, with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Discussions will also revolve around the pivotal role of biomarkers in clinical development, exploring advancements in spatial tissue imaging and the integration of AI technologies in biomarker research. With precision medicine also at the forefront, key opinion leaders will examine how these innovations are shaping the landscape of healthcare and the future of personalized treatment approaches within clinical trials.
speakers
Amanda Klein
Executive Director,
Critical Path Institute
Jian Wang
Director, Bioanalysis/ Biomarker,
Crinetics Pharmaceuticals
Katie Newhall
Vice President, Translational Development,
Cellectis
Matthias von Herrath
Vice President,
Novo Nordisk
Mike Damore
Director, Translational Oncology Lead,
Pfizer
Siddha Kasar
Director,
Takeda Pharmaceuticals
Related Contents
- Are image analysis algorithms for digital pathology compliant with regulatory requirements?
- Next – Gen Digital Pathology Conference
- DIGITAL PATHOLOGY APPLICATIONS: From Clinical Practice to Drug Development
- HALO® 4.0 Sneak Peek
- HALO AI 4.0 Sneak Peek
Date
- Oct 28 - 29 2024
- Expired!
Time
- All Day
More Info
Location
Organizer
-
Oxford Global
-
Phone
+44 1865 248 455 -
Email
help@oxfordglobal.com -
Website
https://oxfordglobal.com
Comments are closed.